https://orcid.org/0000-0002-8460-9838
References
- Jacobi C, Stingele K, Kretz R, et al. Neuromyelitis optica (Devic’s syndrome) as the first manifestation of systemic lupus erythematosus. Lupus. 2006;15(2):107–109.
- Mealy MA, Wingerchuk DM, Greenberg BM, et al. Epidemiology of neuromyelitis optica in the USA. Arch Neurol. 2012;69(9):9.
- Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78(9):665–671.
- D’Cruz DP, Mellor-Pita S, Joven B, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004 Feb;31(2):280–285.
- Birnbaum J, Atri NM, Baer AN, et al. Relationship between neuromyelitis optica spectrum disorder and sjögren’s syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity? Arthritis Care Res (Hoboken). 2017;69(7):1069–1075.
- Liu H-M, Dong C, Zhang Y-Z, et al. Clinical and imaging features of spinal cord type of neuro Behçet disease. Medicine (Baltimore). 2017;96(40):e7958.
- Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473–477.
- Graber DJ, Levy M, Kerr D, et al. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008;5(1):22.
- Duan T, Smith AJ, Verkman AS. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun. 2019;7:1.
- Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189.
- Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non–organ-specific autoimmunity. Arch Neurol. 2008;65(1). DOI:10.1001/archneurol.2007.17
- Haase CG, Schmidt S. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100β and myelin basic protein in patients with Devic’s neuromyelitis optica. Neurosci Lett. 2001;307(2):131–133.
- Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566–569.
- Pittock SJ, Berthele A, Fujihara K, et al. Eculizumab in Aquaporin-4–Positive neuromyelitis optica spectrum disorder. N Engl J Med. 2019;381(7):614–625.